1. Study researchers evaluated the 5-year effectiveness and safety of micropulse transscleral cyclophotocoagulation (MP-TSCPC) for primary and secondary glaucoma and found that it is a safe and effective treatment for lowering IOP and decreasing the number of IOP-lowering medications. 
2. The procedure aims to reduce intraocular pressure while minimizing damage to ocular structures.  
3. Complications included cases of cystoid macular edema, corneal graft rejection, and fibrinous anterior chamber reaction.
4. The investigators reported a decrease in the need for retreatment over time and no statistically significant correlations between the number of preoperative medications and the need for additional surgery.

Source: Ophthalmology and Therapy